AVA vs SRE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score limits distress risk assessment. AVA trades near its analyst target price of $41.00 and slightly below the growth-based intrinsic value of $69.62, but well above the conservative Graham Number of $41.55. Strong recent earnings growth (YoY +56.4%) and a high dividend yield (4.83%) are offset by declining earnings estimate accuracy, insider selling, and weak technical momentum. Relative to sector peers, AVA has below-average revenue growth and profitability but a more stable payout and moderate leverage.
SRE shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
AVA vs SRE: Head-to-Head Comparison
This page compares Avista Corporation (AVA) and Sempra (SRE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.